about
The role of early life environmental risk factors in Parkinson disease: what is the evidence?Developmental pesticide models of the Parkinson disease phenotype.The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin DMortality in levodopa-treated Parkinson's disease.Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.Prevalence of Parkinson's disease in populations of African ancestry: a review.Hormone replacement therapy and risk for neurodegenerative diseases.Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.Outdoor work and risk for Parkinson's disease: a population-based case-control study.Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's diseaseSteroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones.Geographical variations in mortality from Parkinson's disease in Japan, 1977-1985.Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.Vitamin D and Parkinson's disease--a hypothesis.Disparities in the recording of Parkinson's disease on death certificates.Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
P2860
Q24815642-83C90B7D-97C4-4FA3-B053-EF8773246C3BQ24815683-8224794E-D2B5-4C81-9C69-B71EA691FD10Q26748470-375D05DE-E30C-4081-A8C5-89CF89A0F09AQ30414368-62FF0845-4C9C-484C-A797-877E241818AFQ33832927-A30E6AEF-85A4-4597-BDCB-7467850C382BQ34523361-09F6797F-2A28-4C66-A921-D79C6C9E125CQ34784469-490D5A4A-BC52-48CF-A3A3-BA3D7DB0FD83Q35183563-5A5179DE-4759-44B3-AA8E-79A54659C3D4Q35836224-787A2761-43C0-404B-AB54-5A724060FA05Q35884815-4544CA0E-20D0-4D3F-BA16-C88D4F9B3329Q36660748-C52D7969-960D-4A6A-B1D1-4EA73B836AFEQ36885528-333D13B6-1E20-4C5F-8854-328448563BA8Q36900834-E9ED5D2F-5A00-4E69-B28F-0247D4F9024BQ37765941-D501D158-061F-4A1F-A3CF-8C0C30289367Q37905899-298D4D67-E46B-4991-8545-E5A4A37077BEQ39336234-F7886A83-56DA-4557-9107-7E1CC37E708AQ39375739-6181A387-8245-4B3D-BAA7-FDC300719825Q43635677-ADFA64E4-1E49-4A64-86D9-3C3310ADA8F5Q44126277-571B32DF-E212-4009-BE0A-CE556923843EQ48306609-3438C808-8580-4ABC-ACEC-DF5C91D88AF6Q50753028-79D70DB0-0125-44E7-8106-DBA987BA4D14Q53236382-FBAEF9C2-0F45-4693-A78C-3F15DE626FB1
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Parkinsonism death rates by race, sex, and geography.
@en
Parkinsonism death rates by race, sex, and geography.
@nl
type
label
Parkinsonism death rates by race, sex, and geography.
@en
Parkinsonism death rates by race, sex, and geography.
@nl
prefLabel
Parkinsonism death rates by race, sex, and geography.
@en
Parkinsonism death rates by race, sex, and geography.
@nl
P356
P1433
P1476
Parkinsonism death rates by race, sex, and geography.
@en
P2093
Goldberg ID
Kurtzke JF
P304
P356
10.1212/WNL.38.10.1558
P407
P577
1988-10-01T00:00:00Z